vs

Side-by-side financial comparison of ALTISOURCE PORTFOLIO SOLUTIONS S.A. (ASPS) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.

Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $42.3M, roughly 1.7× ALTISOURCE PORTFOLIO SOLUTIONS S.A.). ALTISOURCE PORTFOLIO SOLUTIONS S.A. runs the higher net margin — -16.8% vs -49.0%, a 32.2% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 3.2%). ALTISOURCE PORTFOLIO SOLUTIONS S.A. produced more free cash flow last quarter ($-525.0K vs $-84.7M).

Altisource Portfolio Solutions S.A. is a global provider of integrated technology, data and operational services for the mortgage, real estate and consumer finance sectors. It serves lenders, servicers and investors, offering solutions that streamline asset management and residential property transaction workflows to boost operational efficiency.

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

ASPS vs VRDN — Head-to-Head

Bigger by revenue
VRDN
VRDN
1.7× larger
VRDN
$70.6M
$42.3M
ASPS
Growing faster (revenue YoY)
VRDN
VRDN
+81954.9% gap
VRDN
81958.1%
3.2%
ASPS
Higher net margin
ASPS
ASPS
32.2% more per $
ASPS
-16.8%
-49.0%
VRDN
More free cash flow
ASPS
ASPS
$84.2M more FCF
ASPS
$-525.0K
$-84.7M
VRDN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASPS
ASPS
VRDN
VRDN
Revenue
$42.3M
$70.6M
Net Profit
$-7.1M
$-34.6M
Gross Margin
26.5%
Operating Margin
-15.5%
-56.7%
Net Margin
-16.8%
-49.0%
Revenue YoY
3.2%
81958.1%
Net Profit YoY
18.2%
54.9%
EPS (diluted)
$-1.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPS
ASPS
VRDN
VRDN
Q4 25
$42.3M
Q3 25
$41.9M
$70.6M
Q2 25
$43.3M
Q1 25
$43.4M
Q4 24
$41.0M
Q3 24
$40.5M
Q2 24
$39.1M
Q1 24
$39.5M
Net Profit
ASPS
ASPS
VRDN
VRDN
Q4 25
$-7.1M
Q3 25
$-2.3M
$-34.6M
Q2 25
$16.7M
Q1 25
$-5.3M
Q4 24
$-8.7M
Q3 24
$-9.3M
Q2 24
$-8.3M
Q1 24
$-9.2M
Gross Margin
ASPS
ASPS
VRDN
VRDN
Q4 25
26.5%
Q3 25
27.1%
Q2 25
30.1%
Q1 25
30.7%
Q4 24
30.3%
Q3 24
29.8%
Q2 24
32.5%
Q1 24
31.2%
Operating Margin
ASPS
ASPS
VRDN
VRDN
Q4 25
-15.5%
Q3 25
1.2%
-56.7%
Q2 25
7.5%
Q1 25
7.5%
Q4 24
1.4%
Q3 24
2.7%
Q2 24
5.3%
Q1 24
-1.4%
Net Margin
ASPS
ASPS
VRDN
VRDN
Q4 25
-16.8%
Q3 25
-5.5%
-49.0%
Q2 25
38.5%
Q1 25
-12.1%
Q4 24
-21.3%
Q3 24
-23.0%
Q2 24
-21.1%
Q1 24
-23.2%
EPS (diluted)
ASPS
ASPS
VRDN
VRDN
Q4 25
$-1.02
Q3 25
$-0.22
Q2 25
$1.48
Q1 25
$-0.09
Q4 24
$-4.72
Q3 24
$-2.61
Q2 24
$-2.33
Q1 24
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPS
ASPS
VRDN
VRDN
Cash + ST InvestmentsLiquidity on hand
$26.6M
$490.9M
Total DebtLower is stronger
$191.1M
Stockholders' EquityBook value
$-110.2M
$503.0M
Total Assets
$139.8M
$577.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPS
ASPS
VRDN
VRDN
Q4 25
$26.6M
Q3 25
$28.6M
$490.9M
Q2 25
$30.0M
Q1 25
$30.8M
Q4 24
$29.8M
Q3 24
$28.3M
Q2 24
$29.7M
Q1 24
$29.6M
Total Debt
ASPS
ASPS
VRDN
VRDN
Q4 25
$191.1M
Q3 25
$192.5M
Q2 25
$193.9M
Q1 25
$195.0M
Q4 24
$230.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASPS
ASPS
VRDN
VRDN
Q4 25
$-110.2M
Q3 25
$-104.2M
$503.0M
Q2 25
$-102.7M
Q1 25
$-119.8M
Q4 24
$-157.4M
Q3 24
$-149.4M
Q2 24
$-140.8M
Q1 24
$-133.3M
Total Assets
ASPS
ASPS
VRDN
VRDN
Q4 25
$139.8M
Q3 25
$139.9M
$577.1M
Q2 25
$142.9M
Q1 25
$145.7M
Q4 24
$143.6M
Q3 24
$144.5M
Q2 24
$146.6M
Q1 24
$148.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPS
ASPS
VRDN
VRDN
Operating Cash FlowLast quarter
$-505.0K
$-84.6M
Free Cash FlowOCF − Capex
$-525.0K
$-84.7M
FCF MarginFCF / Revenue
-1.2%
-120.1%
Capex IntensityCapex / Revenue
0.0%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPS
ASPS
VRDN
VRDN
Q4 25
$-505.0K
Q3 25
$718.0K
$-84.6M
Q2 25
$-306.0K
Q1 25
$-5.0M
Q4 24
$-1.4M
Q3 24
$-1.6M
Q2 24
$180.0K
Q1 24
$-2.2M
Free Cash Flow
ASPS
ASPS
VRDN
VRDN
Q4 25
$-525.0K
Q3 25
$697.0K
$-84.7M
Q2 25
$-309.0K
Q1 25
$-5.0M
Q4 24
$-1.4M
Q3 24
Q2 24
Q1 24
FCF Margin
ASPS
ASPS
VRDN
VRDN
Q4 25
-1.2%
Q3 25
1.7%
-120.1%
Q2 25
-0.7%
Q1 25
-11.5%
Q4 24
-3.4%
Q3 24
Q2 24
Q1 24
Capex Intensity
ASPS
ASPS
VRDN
VRDN
Q4 25
0.0%
Q3 25
0.1%
0.2%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
ASPS
ASPS
VRDN
VRDN
Q4 25
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPS
ASPS

Services$39.9M94%
Revenue Relatedto Technology Platformsand Professional Services$2.4M6%

VRDN
VRDN

Segment breakdown not available.

Related Comparisons